https://arxiv.org/api/7RaKbWRK3I3J99mVq9Xa2dq5yDE 2026-03-28T14:38:36Z 4112 165 15 http://arxiv.org/abs/2509.19290v1 2025-09-23T17:54:15Z

Understanding the function of network motifs in an attempt to gain insight into how their combinations create larger reaction networks that drive cellular functions, has been a longstanding pursuit of systems biology. One specific objective within this pursuit is understanding how individual motifs respond to pulsatile and oscillatory signals. This is especially relevant because biochemical networks are often activated by signals that, in nature, occur in the form of pulses and oscillations. A powerful analytical tool for studying such dynamics is the transfer function: a compact frequency-domain description of input-output dynamics. In this work, we derive transfer functions for a set of commonly studied network motifs and characterise their responses to pulsatile and oscillatory inputs. The novelty of this review does not lie in the introduction of new mathematical theorems or biological discoveries, but in bridging well-established frequency domain formalisms from control theory with the analysis of biochemical networks under periodic forcing. In doing so, our contributions are threefold: 1. A systematic derivation and compilation of transfer functions for common network motifs: consolidating results scattered across the literature and establishing a consistent formalism for motif-level transfer functions. 2. Contextualisation of these transfer functions within biological models: extending abstract transfer functions to concrete biological settings so that the results are readily applicable without extensive mathematical labour. 3. Resolution of ambiguity between biological and control-theoretic treatments of feedback: clarifying how feedback loops should be understood within the transfer function formalism and reconciling differences between biology literature and control-oriented literature. This is done by formalising the notion of an intrinsic transfer function.

2025-09-23T17:54:15Z Nguyen H. N. Tran Federico Frascoli Andrew H. A. Clayton http://arxiv.org/abs/2509.19766v1 2025-09-23T17:33:05Z

Advances in genomic medicine accelerate the identi cation of mutations in disease-associated genes, but the pathogenicity of many mutations remains unknown, hindering their use in diagnostics and clinical decision-making. Predictive AI models are generated to combat this issue, but current tools display low accuracy when tested against functionally validated datasets. We show that integrating detailed conformational data extracted from molecular dynamics simulations (MDS) into advanced AI-based models increases their predictive power. We carry out an exhaustive mutational analysis of the disease gene PMM2 and subject structural models of each variant to MDS. AI models trained on this dataset outperform existing tools when predicting the known pathogenicity of mutations. Our best performing model, a neuronal networks model, also predicts the pathogenicity of several PMM2 mutations currently considered of unknown signi cance. We believe this model helps alleviate the burden of unknown variants in genomic medicine.

2025-09-23T17:33:05Z 14 pages , 6 Figures, 2 Tables Communications Biology (Nature) (2025) 8:958 Naeyma N Islam Mathew A Coban Jessica M Fuller Caleb Weber Rohit Chitale Benjamin Jussila Trisha J. Brock Cui Tao Thomas R Caulfield 10.1038/s42003-025-08334-y http://arxiv.org/abs/2509.19410v1 2025-09-23T14:16:18Z

The ongoing opioid crisis highlights the urgent need for novel therapeutic strategies that can be rapidly deployed. This study presents a novel approach to identify potential repurposable drugs for the treatment of opioid addiction, aiming to bridge the gap between transcriptomic data analysis and drug discovery. Speciffcally, we perform a meta-analysis of seven transcriptomic datasets related to opioid addiction by differential gene expression (DGE) analysis, and propose a novel multiscale topological differentiation to identify key genes from a protein-protein interaction (PPI) network derived from DEGs. This method uses persistent Laplacians to accurately single out important nodes within the PPI network through a multiscale manner to ensure high reliability. Subsequent functional validation by pathway enrichment and rigorous data curation yield 1,865 high-conffdence targets implicated in opioid addiction, which are cross-referenced with DrugBank to compile a repurposing candidate list. To evaluate drug-target interactions, we construct predictive models utilizing two natural language processing-derived molecular embeddings and a conventional molecular ffngerprint. Based on these models, we prioritize compounds with favorable binding afffnity proffles, and select candidates that are further assessed through molecular docking simulations to elucidate their receptor-level interactions. Additionally, pharmacokinetic and toxicological evaluations are performed via ADMET (absorption, distribution, metabolism, excretion, and toxicity) proffling, providing a multidimensional assessment of druggability and safety. This study offers a generalizable approach for drug repurposing in other complex diseases beyond opioid addiction. Keywords: Opioid addiction; Interactomic network; Topological perturbation; Differentially expressed gene; Drug repurposin

2025-09-23T14:16:18Z Chunhuan Zhang Sean Cottrell Benjamin Jones Yueying Zhu Huahai Qiu Bengong Zhang Tianshou Zhou Jian Jiang http://arxiv.org/abs/2509.15584v1 2025-09-19T04:38:54Z

The ability to detect whether a species (or dimension) is zero in Chemical Reaction Networks (CRN), Vector Addition Systems, or Petri Nets is known to increase the power of these models -- making them capable of universal computation. While this ability may appear in many forms, such as extending the models to allow transitions to be inhibited, prioritized, or synchronized, we present an extension that directly performs this zero checking. We introduce a new void genesis CRN variant with a simple design that merely increments the count of a specific species when any other species' count goes to zero. As with previous extensions, we show that the model is Turing Universal. We then analyze several other studied CRN variants and show that they are all equivalent through a polynomial simulation with the void genesis model, which does not merely follow from Turing-universality. Thus, inhibitor species, reactions that occur at different rates, being allowed to run reactions in parallel, or even being allowed to continually add more volume to the CRN, does not add additional simulation power beyond simply detecting if a species count becomes zero.

2025-09-19T04:38:54Z Divya Bajaj Jose Luis Castellanos Ryan Knobel Austin Luchsinger Aiden Massie Adrian Salinas Pablo Santos Ramiro Santos Robert Schweller Tim Wylie http://arxiv.org/abs/2402.17131v3 2025-09-17T17:37:29Z

O-GlcNAcylation, a subtype of glycosylation, has the potential to be an important target for therapeutics, but methods to reliably predict O-GlcNAcylation sites had not been available until 2023; a 2021 review correctly noted that published models were insufficient and failed to generalize. Moreover, many are no longer usable. In 2023, a considerably better recurrent neural network (RNN) model was published. This article creates improved models by using a new loss function, which we call the weighted focal differentiable MCC. RNN models trained with this new loss display superior performance to models trained using the weighted cross-entropy loss; this new function can also be used to fine-tune trained models. An RNN trained with this loss achieves state-of-the-art performance in O-GlcNAcylation site prediction with an F$_1$ score of 38.88% and an MCC of 38.20% on an independent test set from the largest dataset available.

2024-02-27T01:53:02Z Pedro Seber http://arxiv.org/abs/2509.12631v1 2025-09-16T03:49:28Z

The Gillespie algorithm and its extensions are commonly used for the simulation of chemical reaction networks. A limitation of these algorithms is that they have to process and update the system after every reaction, requiring significant computation. Another class of algorithms, based on the tau-leaping method, is able to simulate multiple reactions at a time at the cost of decreased accuracy. We present a new algorithm for the exact simulation of chemical reaction networks that is capable of sampling multiple reactions at a time via a first-order approximation similarly to the tau-leaping methods. We prove that the algorithm has an improved runtime complexity compared to existing methods for the exact simulation of chemical reaction networks, and present an efficient and easy to use implementation that outperforms existing methods in practice.

2025-09-16T03:49:28Z Ron Solan Gad Getz http://arxiv.org/abs/2509.12293v1 2025-09-15T14:52:22Z

Antiterminators are essential components of bacterial transcriptional regulation, allowing the control of gene expression in response to fluctuating environmental conditions. Among them, RNA-binding antiterminator proteins play a major role in preventing transcription termination by binding to specific RNA sequences. These RNA-binding antiterminators have been extensively studied for their role in regulating various metabolic pathways. However, their function in modulating the physiology of pathogens requires further investigation. This review focuses on RNA-binding proteins displaying CAT (Co-AntiTerminator) or ANTAR (AmiR and NasR Transcription Antitermination Regulators) domains reported in model bacteria. In particular, their structures, mechanism of action, and target genes will be described. The involvement of the antitermination mechanisms in bacterial pathogenicity is also discussed. This knowledge is crucial for understanding the regulatory mechanisms that control bacterial virulence, and opens up exciting prospects for future research, and potentially new alternative strategies to combat infectious diseases.

2025-09-15T14:52:22Z arXiv admin note: substantial text overlap with arXiv:2410.16752 Diane Soussan Ali Tahrioui Rafael Ruiz de la Haba Adrien Forge Sylvie Chevalier Olivier Lesouhaitier Cécile Muller http://arxiv.org/abs/2501.09087v2 2025-09-12T06:30:02Z

A fluctuation theorem is examined for the first-passage time of a biomolecular machine (e.g., a motor protein or an enzyme) in a nonequilibrium steady-state. For such machines in which the driven, observable process is coupled to a hidden process in a kinetically cooperative fashion, the entropy produced along first-passage trajectories is no longer constant, resulting in a breakdown of this expression. Here, we consider the canonical model for this type of system, a kinetic scheme for conformation-modulated single-enzyme catalysis (a type of continuous-time Markov process with relevance to $β$-galactosidase and human glucokinase), as we explore this fluctuation theorem in cooperative biomolecular networks. Kinetic evaluations are performed using a novel, efficient pathway analysis technique, allowing us to attain surprising and concise results from complex calculations. We find that in the absence of hidden current, a fluctuation theorem can be established for the first-passage time of the observable process, and we demonstrate that this dramatic reduction is a general feature applicable to a wide variety of cooperative networks. The validity of this expression can be experimentally tested, with its violation serving as a unique signature of hidden detailed balance breaking. In addition, we obtain a remarkably compact exact expression for the integrated correction to this first-passage time fluctuation theorem, as well as the general form, revealing a thermodynamic bound on the kinetic branching ratio (a measure of directionality defined as the ratio of the forward observable process probability to the backward one). These results provide detailed insight into the rich connections between dynamic measurements and the underlying nonequilibrium thermodynamics for cooperative biomolecular machines.

2025-01-15T19:13:39Z D. Evan Piephoff Jianshu Cao http://arxiv.org/abs/2509.08263v1 2025-09-10T03:44:02Z

Dynamic Flux Balance Analysis (dFBA) extends the capabilities of FBA to track changes in metabolite concentrations and fluxes over time in response to environmental conditions and cellular processes. The key idea of the method called dynamic parallel FBA (dpFBA) is to assign each species to a separate compartment, and to perform dFBA on the individual compartments while keeping track of the shared pool of external metabolites at each time interval. The software package COBRApy for Constraint-Based Modelling currently offers only an out-of-the-box dFBA implementation for the simulation of the batch growth of a single species over an interval divided in $n$ time steps. Here we describe a simple method to extend COBRApy dFBA to a community of species, by implementing dpFBA without any modification of the current package.

2025-09-10T03:44:02Z 13 pages, 7 figures, 1 Table Domenico L. Gatti http://arxiv.org/abs/2509.08167v1 2025-09-09T22:02:40Z

The dynamics of gene regulatory networks is governed by the interaction between deterministic biochemical reactions and molecular noise. To understand how gene regulatory networks process information during cell state transitions, we study stochastic dynamics derived from a Boolean network model via its representation on the parameter space of Gaussian distributions, equipped with the Fisher information metric. This reformulation reveals that the trajectories of optimal information transfer are gradient flows of the Kullback-Leibler divergence. We demonstrate that the most efficient dynamics require isotropic decay rates across all nodes and that the noise intensity quantitatively determines the potential differentiation between the initial and final states. Furthermore, we show that paths minimizing biological cost correspond to metric geodesics that require noise suppression, leading to biologically irrelevant deterministic dynamics. Our approach frames noise and decay rates as fundamental control parameters for cellular differentiation, providing a geometric principle for the analysis and design of synthetic networks.

2025-09-09T22:02:40Z Miguel Ángel García-Ariza Alessandro Bravetti Pablo Padilla J Roberto Romero-Arias http://arxiv.org/abs/2509.06891v1 2025-09-08T17:11:12Z

Deciphering complex gene-gene interactions remains challenging in transcriptomics as traditional methods often miss higher-order and nonlinear dependencies. This study introduces a quantum-inspired framework leveraging tensor networks (TNs) to optimally map expression data into a lower dimensional representation preserving biological locality. Using Quantum Mutual Information (QMI), a nonparametric measure natural for tensor networks, we quantify gene dependencies and establish statistical significance via permutation testing. This constructs robust interaction networks where the edges reflect biologically meaningful relationships that are resilient to random chance. The approach effectively distinguishes true regulatory patterns from experimental noise and biological stochasticity. To test the proposed method, we recover a gene regulatory network consisted of six pathway genes from single-cell RNA sequencing data comprising over $28.000$ lymphoblastoid cells. Furthermore, we unveil several triadic regulatory mechanisms. By merging quantum physics inspired techniques with computational biology, our method provides novel insights into gene regulation, with applications in disease mechanisms and precision medicine.

2025-09-08T17:11:12Z 12 pages, 6 figures Olatz Sanz Larrarte Borja Aizpurua Reza Dastbasteh Ruben M. Otxoa Josu Etxezarreta Martinez http://arxiv.org/abs/2509.06268v1 2025-09-08T01:13:56Z

Competitive inhibitors can, paradoxically, stimulate an enzymatic reaction at low to moderate doses. Competitive inhibition of an enzyme occurs when an inhibitor binds to the enzyme's binding site and blocks the enzyme's target molecule from binding. We recently proposed a detailed but straightforward mass action model for competitive inhibition of phosphoglycerate kinase 1 (PGK1) by Terazosin (TZ). The full PGK1 model has two substrates and two products which can be bound and released in either order, known as a random bi-bi mechanism. This model, with no further modification, predicts an increased reaction rate at low or moderate TZ doses, suggesting that stimulation is an intrinsic feature of competitive inhibition in enzymes with two products. This mechanism can aid in the development of novel therapies, particularly since enzyme activators are more rare and difficult to design than inhibitors. Here we propose a three-timescale reduction of that detailed model and show that the resulting rate equation retains three essential attributes of competitive inhibitor stimulation. These attributes are the biphasic dose response, the dependence on the relative rates of product dissociation from the binary and ternary complexes, and the parameter region where stimulation is possible. The resulting rate equation is a rational function which is a Monod function of each substrate, but quadratic in the denominator as a function of inhibitor dose.

2025-09-08T01:13:56Z 26 pages including references, 10 figures Garrett Young Mitchell Riley Colleen Mitchell http://arxiv.org/abs/2509.05481v1 2025-09-05T20:13:24Z

Biomolecular Neural Networks (BNNs), artificial neural networks with biologically synthesizable architectures, achieve universal function approximation capabilities beyond simple biological circuits. However, training BNNs remains challenging due to the lack of target data. To address this, we propose leveraging Signal Temporal Logic (STL) specifications to define training objectives for BNNs. We build on the quantitative semantics of STL, enabling gradient-based optimization of the BNN weights, and introduce a learning algorithm that enables BNNs to perform regression and control tasks in biological systems. Specifically, we investigate two regression problems in which we train BNNs to act as reporters of dysregulated states, and a feedback control problem in which we train the BNN in closed-loop with a chronic disease model, learning to reduce inflammation while avoiding adverse responses to external infections. Our numerical experiments demonstrate that STL-based learning can solve the investigated regression and control tasks efficiently.

2025-09-05T20:13:24Z Eric Palanques-Tost Hanna Krasowski Murat Arcak Ron Weiss Calin Belta http://arxiv.org/abs/2509.03336v1 2025-09-03T14:12:32Z

miRNA mRNA relations are closely linked to several biological processes and disease mechanisms In a recent study we tested the performance of large language models LLMs on extracting miRNA mRNA relations from PubMed PubMedBERT achieved the best performance of 0.783 F1 score for miRNA mRNA Interaction Corpus MMIC Here we first applied the finetuned PubMedBERT model to extract miRNA mRNA relations from PubMed for chronic obstructive pulmonary disease COPD Alzheimers disease AD stroke type 2 diabetes mellitus T2DM chronic liver disease and cancer Next we retrieved miRNA drug relations using KinderMiner a literature mining tool for relation extraction Then we constructed three interaction networks 1 disease centric network 2 drug centric network and 3 miRNA centric network comprising 3497 nodes and 16417 edges organized as a directed graph to capture complex biological relationships Finally we validated the drugs using MIMIC IV Our integrative approach revealed both established and novel candidate drugs for diseases under study through 595 miRNA drug relations extracted from PubMed To the best of our knowledge this is the first study to systematically extract and visualize relationships among four distinct biomedical entities miRNA mRNA drug and disease

2025-09-03T14:12:32Z Sharanya Manoharan Balu Bhasuran Oviya Ramalakshmi Iyyappan Mohamed Saleem Abdul Shukkoor Malathi Sellapan Kalpana Raja http://arxiv.org/abs/2509.03330v1 2025-09-03T14:05:56Z

Despite the thousands of genes implicated in age-related phenotypes, effective interventions for aging remain elusive, a lack of advance rooted in the multifactorial nature of longevity and the functional interconnectedness of the molecular components implicated in aging. Here, we introduce a network medicine framework that integrates 2,358 longevity-associated genes onto the human interactome to identify existing drugs that can modulate aging processes. We find that genes associated with each hallmark of aging form a connected subgraph, or hallmark module, a discovery enabling us to measure the proximity of 6,442 clinically approved or experimental compounds to each hallmark. We then introduce a transcription-based metric, $pAGE$, which evaluates whether the drug-induced expression shifts reinforce or counteract known age-related expression changes. By integrating network proximity and $pAGE$, we identify multiple drug repurposing candidate that not only target specific hallmarks but act to reverse their aging-associated transcriptional changes. Our findings are interpretable, revealing for each drug the molecular mechanisms through which it modulates the hallmark, offering an experimentally falsifiable framework to leverage genomic discoveries to accelerate drug repurposing for longevity.

2025-09-03T14:05:56Z Bnaya Gross Joseph Ehlert Vadim N. Gladyshev Joseph Loscalzo Albert-László Barabási